These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 10869187)

  • 41. Purification and properties of a NAD(P)H:flavin oxidoreductase from the luminous bacterium, Beneckea harveyi.
    Michaliszyn GA; Wing SS; Meighen EA
    J Biol Chem; 1977 Nov; 252(21):7495-9. PubMed ID: 303240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Change of nucleotide specificity and enhancement of catalytic efficiency in single point mutants of Vibrio harveyi aldehyde dehydrogenase.
    Zhang L; Ahvazi B; Szittner R; Vrielink A; Meighen E
    Biochemistry; 1999 Aug; 38(35):11440-7. PubMed ID: 10471295
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene cloning, purification, and characterization of NfsB, a minor oxygen-insensitive nitroreductase from Escherichia coli, similar in biochemical properties to FRase I, the major flavin reductase in Vibrio fischeri.
    Zenno S; Koike H; Tanokura M; Saigo K
    J Biochem; 1996 Oct; 120(4):736-44. PubMed ID: 8947835
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Conversion of NfsA, the major Escherichia coli nitroreductase, to a flavin reductase with an activity similar to that of Frp, a flavin reductase in Vibrio harveyi, by a single amino acid substitution.
    Zenno S; Kobori T; Tanokura M; Saigo K
    J Bacteriol; 1998 Jan; 180(2):422-5. PubMed ID: 9440535
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Equilibrium and transient state spectrophotometric studies of the mechanism of reduction of the flavoprotein domain of P450BM-3.
    Sevrioukova I; Shaffer C; Ballou DP; Peterson JA
    Biochemistry; 1996 Jun; 35(22):7058-68. PubMed ID: 8679531
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NADPH-sulfite reductase from Escherichia coli. A flavin reductase participating in the generation of the free radical of ribonucleotide reductase.
    Covès J; Nivière V; Eschenbrenner M; Fontecave M
    J Biol Chem; 1993 Sep; 268(25):18604-9. PubMed ID: 8360156
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MSMEG_3955 from Mycobacterium smegmatis is a FMN bounded homotrimeric NAD(P)H:Flavin mononucleotide (FMN) oxidoreductase.
    Khosla N; Thayil SM; Kaur R; Kesavan AK
    BMC Microbiol; 2021 Nov; 21(1):319. PubMed ID: 34798816
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanistic investigation of a highly active phosphite dehydrogenase mutant and its application for NADPH regeneration.
    Woodyer R; Zhao H; van der Donk WA
    FEBS J; 2005 Aug; 272(15):3816-27. PubMed ID: 16045753
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stereospecificity of hydride transfer and substrate specificity for FMN-containing NAD(P)H-flavin oxidoreductase from the luminescent bacterium, Vibrio fischeri ATCC 7744.
    Inouye S; Nakamura H
    Biochem Biophys Res Commun; 1994 Nov; 205(1):275-81. PubMed ID: 7999036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The NAD(P)H:flavin oxidoreductase from Escherichia coli. Evidence for a new mode of binding for reduced pyridine nucleotides.
    Nivière V; Fieschi F; Dećout JL; Fontecave M
    J Biol Chem; 1999 Jun; 274(26):18252-60. PubMed ID: 10373427
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biochemical characterization of NfsA, the Escherichia coli major nitroreductase exhibiting a high amino acid sequence homology to Frp, a Vibrio harveyi flavin oxidoreductase.
    Zenno S; Koike H; Kumar AN; Jayaraman R; Tanokura M; Saigo K
    J Bacteriol; 1996 Aug; 178(15):4508-14. PubMed ID: 8755878
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aminobacter aminovorans NADH:flavin oxidoreductase His140: a highly conserved residue critical for NADH binding and utilization.
    Russell TR; Tu SC
    Biochemistry; 2004 Oct; 43(40):12887-93. PubMed ID: 15461461
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complex formation between Vibrio harveyi luciferase and monomeric NADPH:FMN oxidoreductase.
    Jeffers CE; Nichols JC; Tu SC
    Biochemistry; 2003 Jan; 42(2):529-34. PubMed ID: 12525181
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Purification, characterization, and overexpression of flavin reductase involved in dibenzothiophene desulfurization by Rhodococcus erythropolis D-1.
    Matsubara T; Ohshiro T; Nishina Y; Izumi Y
    Appl Environ Microbiol; 2001 Mar; 67(3):1179-84. PubMed ID: 11229908
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loop 6 and the β-hairpin flap are structural hotspots that determine cofactor specificity in the FMN-dependent family of ene-reductases.
    Kerschbaumer B; Totaro MG; Friess M; Breinbauer R; Bijelic A; Macheroux P
    FEBS J; 2024 Apr; 291(7):1560-1574. PubMed ID: 38263933
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kinetic, spectroscopic and thermodynamic characterization of the Mycobacterium tuberculosis adrenodoxin reductase homologue FprA.
    McLean KJ; Scrutton NS; Munro AW
    Biochem J; 2003 Jun; 372(Pt 2):317-27. PubMed ID: 12614197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heterologous expression of an endogenous rat cytochrome b(5)/cytochrome b(5) reductase fusion protein: identification of histidines 62 and 85 as the heme axial ligands.
    Davis CA; Dhawan IK; Johnson MK; Barber MJ
    Arch Biochem Biophys; 2002 Apr; 400(1):63-75. PubMed ID: 11913972
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vibrio harveyi flavin reductase--luciferase fusion protein mimics a single-component bifunctional monooxygenase.
    Jawanda N; Ahmed K; Tu SC
    Biochemistry; 2008 Jan; 47(1):368-77. PubMed ID: 18067321
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interaction of NADP(H) with oxidized and reduced P450 reductase during catalysis. Studies with nucleotide analogues.
    Murataliev MB; Feyereisen R
    Biochemistry; 2000 May; 39(17):5066-74. PubMed ID: 10819972
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human cytochrome P450 oxidoreductase deficiency caused by the Y181D mutation: molecular consequences and rescue of defect.
    Marohnic CC; Panda SP; McCammon K; Rueff J; Masters BS; Kranendonk M
    Drug Metab Dispos; 2010 Feb; 38(2):332-40. PubMed ID: 19884324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.